Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alison R. Walker
Management of Patients With Cytogenetically Normal Acute Myeloid Leukemia Who Have Neither Favorable Nor Unfavorable Markers
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
A Novel Regimen for Relapsed/Refractory Adult Acute Myeloid Leukemia Using a KMT2A Partial Tandem Duplication Targeted Therapy: Results of Phase 1 Study NCI 8485
Haematologica
Hematology
Related publications
"Patients With Terminal Cancer" Who Have Neither Terminal Illness Nor Cancer.
BMJ
Candida Albicans Cervical Lymphadenitis in Patients Who Have Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Overexpression of ATP1B1 Predicts an Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
Oncotarget
Oncology
High Expression of RUNX1 Is Associated With Poorer Outcomes in Cytogenetically Normal Acute Myeloid Leukemia
Oncotarget
Oncology
Impact of Fludarabine-Based Induction Therapy on Outcome of FLT3−/NPM1+ Cytogenetically Normal Acute Myeloid Leukemia
American Journal of Hematology
Hematology
High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Gene and Protein Analysis Reveals That P53 Pathway Is Functionally Inactivated in Cytogenetically Normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia
BMC Medical Genomics
Genetics
High Expression of miR-25 Predicts Favorable Chemotherapy Outcome in Patients With Acute Myeloid Leukemia
Cancer Cell International
Cancer Research
Oncology
Genetics
New Molecular Markers in Acute Myeloid Leukemia
